Germany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The pharmaceuticals sector in Germany is poised for significant expansion, with projections indicating a USD 24.9 billion increase from 2023 to 2028. The market's trajectory suggests a Compound Annual Growth Rate (CAGR) of 6.79% during the forecast period, underscoring the vitality of this industry within the national economy. Key Growth Drivers The German pharmaceuticals market's progression can be attributed to multiple convergent factors. There is a notable rise in capital investment within the pharmaceutical sector, aligning with anticipated demographic shifts, such as the increase in the aging population. Furthermore, the consolidation of the industry through mergers and acquisitions is catalyzing market growth. These elements are collaboratively fostering a conducive environment for market expansion. Market Segmentation Analysis An in-depth segmentation of the market reveals a bifurcation across distribution channels, with pharmacies and clinics representing the primary
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Growing Biosimilars Business, New Partnerships Support ABT Stock [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company [Yahoo! Finance]Yahoo! Finance
- Is Abbott Stock Worth Buying at a Discounted P/S Valuation? [Yahoo! Finance]Yahoo! Finance
- The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website